Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413

Nivolumab plus Ipilimumab in Advanced Melanoma

Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230

T cell exhaustion

Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 1×

Cancer immunotherapy comes of age

Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893

Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233

Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis

Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204

Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer

Yan, Y., Huang, Z., Cai, J., Tang, P., Zhang, F., Tan, M., & Shen, B. (2020) · Aging · doi:10.18632/aging.202327 · Cited by 16

Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance

Lin, X., Zhou, W., Liu, Z., Cao, W., & Lin, C. (2022) · Oral Diseases · doi:10.1111/odi.14411 · Cited by 16

Metabolic regulation of macrophages in tumor microenvironment

Kim, J., & Bae, J. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000390 · Cited by 16

Metabolic orchestration of T lineage differentiation and function

Yong, C. S. M., Moussa, D. A., Cretenet, G., Kinet, S., Dardalhon, V., & Taylor, N. N. (2017) · FEBS Letters · doi:10.1002/1873-3468.12849 · Cited by 16

Metal–Phenolic Nanomedicines Targeting Fatty Acid Metabolic Reprogramming to Overcome Immunosuppression in Radiometabolic Cancer Therapy

Wang, G., Wang, D., Xia, L., Lian, J., Zhang, Q., Shen, D., Wang, Z., & Dai, Y. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c21028 · Cited by 15

Endoplasmic Reticulum Stress: Triggers Microenvironmental Regulation and Drives Tumor Evolution

Peng, C., Wang, J., Wang, S., Zhao, Y., Wang, H., Wang, Y., Ma, Y., & Yang, J. (2025) · Cancer Medicine · doi:10.1002/cam4.70684 · Cited by 15

Age- and diet-instructed metabolic rewiring of the tumor–immune microenvironment

Plata-Gómez, A. B., & Ho, P. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241102 · Cited by 17

Persistent lineage plasticity driving lung cancer development and progression

Meng, F., Li, J., Xia, Z., Wang, Q., Sun, Q., Wang, S., Xu, L., & Yin, R. H. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70458 · Cited by 17

Lactate signaling and immune suppression in tumors: mechanisms and therapeutic implications

Wang, X., Xiong, D., Cui, S., Duan, B., Ding, G., Huang, Y., & Wang, Q. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01186-6 · Cited by 16

Metabolic heterogeneity and immunocompetence of infiltrating immune cells in the breast cancer microenvironment (Review)

Chen, H., Sun, Y., Yang, Z., Yin, S., Li, Y., Tang, M., Zhu, J.-P., & Zhang, F. (2021) · Oncology Reports · doi:10.3892/or.2021.7946 · Cited by 15

Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy

Jing, Z., Gao, J., Li, J., Niu, F., Tian, L., Nan, P., Sun, Y., Xie, X., Zhu, Y., Zhao, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.06.016 · Cited by 15

The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors

Hunt, E. G., Andrews, A. M., Larsen, S. R., & Thaxton, J. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.867341 · Cited by 16

P2 Receptors: Novel Disease Markers and Metabolic Checkpoints in Immune Cells

Vultaggio-Poma, V., & Virgilio, F. D. (2022) · Biomolecules · doi:10.3390/biom12070983 · Cited by 15

FLIM of NAD(P)H in Lymphatic Nodes Resolves T-Cell Immune Response to the Tumor

Izosimova, A. V., Shirmanova, M. V., Shcheslavskiy, V. I., Sachkova, D. A., Mozherov, A. M., Sharonov, G. V., Вадимовна, З. Е., & Yuzhakova, D. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415829 · Cited by 16

The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming

Wang, Z., Liu, N., Yang, Y., & Tu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1349867 · Cited by 18

Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors

Spiga, M., Martini, E., Maffia, M. C., Ciceri, F., Ruggiero, E., Potenza, A., & Bonini, C. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01011-y · Cited by 16

Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond

Yang, Z., Ha, B., Wu, Q., Ren, F., Yin, Z., & Zhang, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1544532 · Cited by 18

Drosophilaas a Model System to Study Nonautonomous Mechanisms Affecting Tumour Growth and Cell Death

Parvy, J.-P., Hodgson, J. A., & Cordero, J. B. (2018) · BioMed Research International · doi:10.1155/2018/7152962 · Cited by 17

Metabolic changes and interaction of tumor cell, myeloid-derived suppressor cell and T cell in hypoxic microenvironment

Ou, X., & Lv, W. (2020) · Future Oncology · doi:10.2217/fon-2019-0692 · Cited by 15

Metabolic interventions: A new insight into the cancer immunotherapy

Yu, T., Dong, T., Eyvani, H., Fang, Y., Wang, X., Zhang, X., & Lu, X. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108659 · Cited by 16

Immuno-metabolic changes in herpes virus infection

Chattopadhyay, D., Mukhopadhyay, A., Ojha, D., Sadhukhan, P. C., & Dutta, S. (2018) · Cytokine · doi:10.1016/j.cyto.2018.06.028 · Cited by 16

Oncogenic kinases and perturbations in protein synthesis machinery and energetics in neoplasia

Uchenunu, O., Pollak, M., Topisirović, I., & Hulea, L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0058 · Cited by 16

A comparative view on vitamin C effects on αβ- versus γδ T-cell activation and differentiation

Peters, C., Kouakanou, L., & Kabelitz, D. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1mr1219-245r · Cited by 16

Impact of Immunometabolism on Cancer Metastasis: A Focus on T Cells and MacrophagesPreprint

Flerin, N. C., Pinioti, S., Menga, A., Castegna, A., & Mazzone, M. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037044 · Cited by 16

Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how

Zhai, Y., Liang, X., & Deng, M. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.06.04 · Cited by 14

Crosstalk between the tumor immune microenvironment and metabolic reprogramming in pancreatic cancer: new frontiers in immunotherapy

Shi, T., Cui, X., Wang, J., Liu, G., Meng, J., & Zhang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1564603 · Cited by 15

Mitochondrial bioenergetics and networks in melanoma: an update

Giannitti, G., Paganoni, A. J. J., Marchesi, S., Garavaglia, R., & Fontana, F. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02155-4 · Cited by 15

Tumor Microenvironment Metabolism‐Modulating Nanomedicines for Enhancing Anti‐Tumor Immunity

Chen, J., Fei, S., Cao, Z., Liu, X., Ji, W., Chen, H., Niu, Y., & Yang, Z. (2025) · Small · doi:10.1002/smll.202509685 · Cited by 17

The return of metabolism: biochemistry and physiology of glycolysis

Grüning, N., Agostini, F., Caldana, C., Hartl, J., Heinemann, M., Keller, M. A., Krüsemann, J. L., Lamperti, C., Linster, C. L., Lindner, S. N., et al. (2025) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.70104 · Cited by 18

mTOR participates in the formation, maintenance, and function of memory CD8+T cells regulated by glycometabolism

Cai, X., Li, H., Wang, M., Chu, E., Wei, N., Lin, J., Hu, Y. F., Dai, J., Chen, A., Zheng, H., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115197 · Cited by 15

Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade

Tian, W., Qin, G., Jia, M., Li, W., Cai, W., Wang, H., Zhao, Y., Bao, X., Wei, W., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1198551 · Cited by 16

Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4+ T Cells—Implications for the Pathogenesis of Systemic Lupus Erythematosus

Park, J. S., & Perl, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310749 · Cited by 14

Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer

Chen, X., Bai, G., Zang, R., Song, P., Bie, F., Huai, Q., Li, Y., Liu, Y., Zhou, B., Bie, Y., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101725 · Cited by 13

The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade

Cui, Y., Sun, Y., Li, D., Zhang, Y., Zhang, Y., Cao, D., & Cao, X. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1275543 · Cited by 16

Advanced nanomaterials for enhanced immunotherapy via metabolic regulation

Li, X., Ding, B., Zheng, P., Ma, P., & Lin, J. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215540 · Cited by 14

Metabolic and senescence characteristics associated with the immune microenvironment in ovarian cancer

Xiong, J., Fu, Y., Huang, J., Wang, Y., Jin, X., Wan, X., Huang, L., & Huang, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265525 · Cited by 14

Targeting immuno-metabolism to improve anti-cancer therapies

Beezhold, K., & Byersdorfer, C. A. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.005 · Cited by 14

The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ

Wang, L., Yang, X., Li, D., Liang, Z., Chen, Y., Ma, G., Wang, Y., Li, Y., Liang, Y., & Niu, H. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s180505 · Cited by 15

p722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8+ T lymphocytes

Topin-Ruiz, S., Mellinger, A., Lepeltier, É., Bourreau, C., Fouillet, J., Riou, J., Jaouen, G., Martin, L., Passirani, C., & Clere, N. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120111 · Cited by 14

Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer

Li, Y., Hu, L., Peng, X., Xu, H., Tang, B., & Xu, C. S. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.102 · Cited by 13

Tracing insights into human metabolism using chemical engineering approaches

Cordes, T., & Metallo, C. M. (2016) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2016.08.019 · Cited by 14

Cancer Cell Metabolism: Implications for X-ray and Particle Radiation Therapy

Sertorio, M. G., Perentesis, J. P., Vatner, R. E., Mascia, A. E., Zheng, Y., & Wells, S. I. (2018) · International Journal of Particle Therapy · doi:10.14338/ijpt-18-00023.1 · Cited by 14

Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer

Aria, H., Ghaedrahmati, F., & Ganjalıkhani-Hakemi, M. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30303 · Cited by 14

Même l’effet Warburg est oxydable: Coopération métabolique et développement tumoral

Cordier–Bussat, M., Thibert, C., Sujobert, P., Genestier, L., Fontaine, E. M., & Billaud, M. (2018) · HAL · doi:10.1051/medsci/20183408017 · Cited by 7

Metabolic wiring of murine T cell and intraepithelial lymphocyte maintenance and activation

Veldhoen, M., Blankenhaus, B., Konjar, Š., & Ferreira, C. (2018) · European Journal of Immunology · doi:10.1002/eji.201646745 · Cited by 14

Identification of 14 Differentially-Expressed Metabolism-Related Genes as Potential Targets of Gastric Cancer by Integrated Proteomics and Transcriptomics

Zhang, Y., Liu, W., Feng, W., Wang, X., Lei, T., Chen, Z., & Song, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.816249 · Cited by 13

Metabolic Dialogue Shapes Immune Response in the Tumor Microenvironment

Gao, F., Shah, R., Xin, G., & Wang, R. (2025) · European Journal of Immunology · doi:10.1002/eji.202451102 · Cited by 15

Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma

Mizuno, T., Kamai, T., Tsuzuki, T., Nishihara, D., Kijima, T., Arai, K., & Yoshida, K. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03011-5 · Cited by 13

Respiratory Complex I dysfunction in cancer: from a maze of cellular adaptive responses to potential therapeutic strategies

Sollazzo, M., Luise, M. D., Lemma, S., Bressi, L., Iorio, M. C., Miglietta, S., Milioni, S., Kurelac, I., Iommarini, L., Gasparre, G., et al. (2021) · FEBS Journal · doi:10.1111/febs.16218 · Cited by 13

Tumor infiltrating lymphocytes and radiological picture of the tumor

Frankowska, K., Zarobkiewicz, M. K., Dąbrowska, I., & Bojarska-Junak, A. A. (2023) · Medical Oncology · doi:10.1007/s12032-023-02036-3 · Cited by 13

13C tracer analysis reveals the landscape of metabolic checkpoints in human CD8+ T cell differentiation and exhaustion

Kirchmair, A., Nemati, N., Lamberti, G., Trefny, M. P., Krogsdam, A., Siller, A., Hörtnagl, P., Schumacher, P., Sopper, S., Sandbichler, A. M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1267816 · Cited by 15

Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity

Zhang, S., Zhang, X., Yang, H., Liang, T., & Bai, X. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189022 · Cited by 14

Covalent Plant Natural Product that Potentiates Antitumor Immunity

Takemoto, M., Delghandi, S., Abo, M., Yurimoto, K., Odagi, M., Singh, V. P., Wang, J., Nakagawa, R., Sato, S., Takemoto, Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c17837 · Cited by 14

Sugars and fat – A healthy way to generate functional regulatory T cells

Gabriel, S. S., & Kallies, A. (2016) · European Journal of Immunology · doi:10.1002/eji.201646663 · Cited by 13

Immune landscape and therapeutic strategies: new insights into PD-L1 in tumors

Yuan, W., Xiao, C., Lao, X., Zheng, L., & Kuang, D. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03637-1 · Cited by 13

Principles of reproducible metabolite profiling of enriched lymphocytes in tumors and ascites from human ovarian cancer

Kilgour, M. K., MacPherson, S., Zacharias, L. G., LeBlanc, J., Babinszky, S., Kowalchuk, G., Parks, S. K., Sheldon, R. D., Jones, R. G., DeBerardinis, R. J., et al. (2022) · Nature Protocols · doi:10.1038/s41596-022-00729-z · Cited by 13

The tumor microenvironment: Thousand obstacles for effector T cells

Massa, C., & Seliger, B. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.004 · Cited by 13

Mannose Metabolism Is Essential for Th1 Cell Differentiation and IFN-γ Production

Zygmunt, B. M., Węgrzyn, A., Gajska, W., Yevsa, T., Chodaczek, G., & Guzmán, C. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700042 · Cited by 15

Plasticity in T-cell mitochondrial metabolism: A necessary peacekeeper during the troubled times of persistent HIV-1 infection

Loucif, H., Dagenais-Lussier, X., Beji, C., Telittchenko, R., Routy, J., & van Grevenynghe, J. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.02.004 · Cited by 12

Correction: Differential Fuel Requirements of Human NK Cells and Human CD8 T Cells: Glutamine Regulates Glucose Uptake in Strongly Activated CD8 T Cells

Presnell, S. R., Spear, H. K., Durham, J., Riddle, T., Applegate, A., & Lutz, C. T. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000065 · Cited by 14

Targeting the crosstalk between glutamine metabolism and tumor immune microenvironment for lung cancer immunotherapy

Li, J., Li, X., Wang, S., Zhang, Y., Zhao, S., Zhang, D., Meng, X., Zhang, Y., & Lin, J. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.20240069 · Cited by 12

Piezo-catalytic immunotherapy: mechanisms and feasibility in cancer treatment

Chen, Z., Sang, L., Bian, D., Liu, Y., & Bai, Z. (2025) · Theranostics · doi:10.7150/thno.114676 · Cited by 13

Insights into the Mechanisms of Immune‐Checkpoint Inhibitors Gained from Spatiotemporal Dynamics of the Tumor Microenvironment

Zhang, Y., & Liu, Z. (2025) · Advanced Science · doi:10.1002/advs.202508692 · Cited by 13

CD8+ T cell stressors converge on shared metabolic–epigenetic networks

Shangguan, Y., Wang, J., Ho, P., & Xu, Y. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.08.009 · Cited by 14

Bimetallic Nanozyme Amplifier for Synergistic Ferroptosis‐Cuproptosis and Metabolic Reprogramming to Reshape Immunosuppressive Tumor Microenvironment

Luo, J., Huang, K., Yi, X., Lu, P., Xie, H., Li, W., Zeng, Q., He, F., Wang, D., & Wang, L. (2025) · Advanced Science · doi:10.1002/advs.202512764 · Cited by 12

CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead

Shaer, N. S. H. A., Masoud, I., Tleyjeh, A., Al-Attas, A. A., Al-Attas, M. A., Khan, M. I., & Yaqinuddin, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1796675 · Cited by 15

Modelling cancer metabolism in vitro: current improvements and future challenges

Dragic, H., Chaveroux, C., Cosset, E. C., & Manié, S. N. (2022) · FEBS Journal · doi:10.1111/febs.16704 · Cited by 14

Reprogramming T-cell metabolism to enhance adoptive cell therapies

Kates, M., & Saibil, S. D. (2024) · International Immunology · doi:10.1093/intimm/dxae007 · Cited by 13

Tuning cellular metabolism for cancer virotherapy

Xiong, D., Wang, Q., Wang, W., & Sun, Z. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216924 · Cited by 12

Is glucose the scapegoat for tumor evasion?

Raines, L. N., & Huang, S. C. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.06.006 · Cited by 12

Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer

Choi, S. Y. C., Ribeiro, C. F., Wang, Y. Z., Loda, M. F., Plymate, S. R., & Uo, T. (2022) · Biomolecules · doi:10.3390/biom12111590 · Cited by 13

Overcoming current challenges to T-cell receptor therapy via metabolic targeting to increase antitumor efficacy, durability, and tolerability

Mao, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1056622 · Cited by 13

Human cytomegalovirus induces neuronal enolase to support virally mediated metabolic remodeling

Moreno, I., Rodríguez-Sánchez, I., Schafer, X., & Munger, J. C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205789119 · Cited by 12

Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma

Hasanpourghadi, M., Chekaoui, A., Kurian, S., Kurupati, R. K., Ambrose, R., Giles‐Davis, W., Saha, A., Xu, X., & Ertl, H. C. J. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.100744 · Cited by 12

Metabolites can regulate stem cell behavior through the STAT3/AKT pathway in a similar trend to that under hypoxic conditions

Jeong, G., Kang, D., Kim, A., Han, K. H., Jeon, H. R., & Kim, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-42669-x · Cited by 12

Transcriptomic changes associated with PCK1 overexpression in hepatocellular carcinoma cells detected by RNA-seq

Jin, X., Zhang, Y., Tuo, L., Liu, R., Gou, D., Liang, L., Chen, C., Xia, J. L., Tang, N., & Wang, K. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.04.004 · Cited by 12

Tissue-Specific Dependence of Th1 Cells on the Amino Acid Transporter SLC38A1 in InflammationPreprint

Sugiura, A., Beier, K. L., Chi, C., Heintzman, D. R., Ye, X., Wolf, M. M., Patterson, A. R., Cephus, J.-Y., Hong, H. S., Lyssiotis, C. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.13.557496 · Cited by 12

Mitochondrial control of glycerolipid synthesis by a PEP shuttle

Yamamuro, T., Katoh, D., Silva, G. M., Nishida, H., Oikawa, S., Higuchi, Y., Wang, D., Fujimoto, M., Yoshida, N., Li, M., et al. (2026) · Cell · doi:10.1016/j.cell.2026.02.017 · Cited by 11

Brd4 Regulates the Homeostasis of CD8+ T-Lymphocytes and Their Proliferation in Response to Antigen Stimulation

Peng, Z., Zhang, Y., Ma, X., Zhou, M., Wu, S., Song, Z., Yuan, Y., Chen, Y., Li, Y., Wang, G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.728082 · Cited by 12

A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomes

Pedrosa, L., Foguet, C., Oliveres, H., Archilla, I., de Herreros, M. G., Rodríguez, A., Postigo, A. A., Benítez‐Ribas, D., Camps, J., Cuatrecasas, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.926304 · Cited by 11

The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma

Wu, J., Meng, F., Ran, D., Song, Y., Dang, Y., Lai, F., Yang, L., Deng, M., Song, Y., & Zhu, J. (2023) · Metabolites · doi:10.3390/metabo13060734 · Cited by 12

Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy

Zhao, J., Dong, Y., Bai, H., Bai, F., Yan, X., Duan, J., Wan, R., Xu, J., Fei, K., Wang, J., et al. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100596 · Cited by 12

Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment

Cheng, H., & Zheng, Y. (2024) · PeerJ · doi:10.7717/peerj.16825 · Cited by 13

Cellular diversity through space and time: adding new dimensions to GBM therapeutic development

Johnson, A., & López-Bertoni, H. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1356611 · Cited by 11

IL3-Driven T Cell–Basophil Crosstalk Enhances Antitumor Immunity

Wei, J. N., Mayberry, C. L., Lv, X., Hu, F., Sears, J. D., Khan, T., Logan, N. A., Sears, J. D., Chaussabel, D., & Chang, C. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0851 · Cited by 11

Metabolic dialogues: regulators of chimeric antigen receptor T cell function in the tumor microenvironment

Moraly, J., Kondo, T., Benzaoui, M., DuSold, J., Talluri, S., Pouzolles, M., Chien, C. D., Dardalhon, V., & Taylor, N. N. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13691 · Cited by 12

Combination of radiotherapy and PD-L1 blockade induces abscopal responses in EGFR-mutated lung cancer through activating CD8+ T cells

Xia, W.-Y., Shen, Y.-J., Zhang, C.-C., Qian, L., Wang, H., Wang, K., Jin, H.-Z., Zhu, X., Ding, Z.-P., Zhang, Q., et al. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102074 · Cited by 12

Hexokinase2-engineered T cells display increased anti-tumor function

Zur-Toledano, R., Zurinam, S. D., Radman, M., Balouka, E. F., Borodianskiy-Shteinberg, T., Saur, D., & Cohen, C. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1477929 · Cited by 11

Engineered Probiotics-Based Biohybrid-Driven Tumor Metabolic Remodeling To Boost Tumor Photoimmunotherapy

Hu, Q., Huang, X., Wang, T., Lu, Z., Sun, D., & Jin, Y. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c02850 · Cited by 11

Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived States

Khurana, P., Burudpakdee, C., Grupp, S. A., Beier, U. H., Barrett, D. M., & Bassiri, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700374 · Cited by 11

Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis

Markouli, M., Strepkos, D., Papavassiliou, K. A., Papavassiliou, A. G., & Piperi, C. (2022) · Cancers · doi:10.3390/cancers14112655 · Cited by 12

Immuno-onco-metabolism and Therapeutic Resistance

Mir, M. A., Aisha, S., Nisar, S., Qayoom, H., & Mehraj, U. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_3 · Cited by 11

Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells

Hyroššová, P., Aragó, M., Muñoz‐Pinedo, C., Viñals, F., García-Rovés, P. M., Escolano, C., Méndez‐Lucas, A., & Perales, J. C. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05177-x · Cited by 11

Low glucose availability potentiates the effects of metformin on model T cell activation and exhaustion markers in vitro

Repas, J., Peternel, L., Sourij, H., & Pavlin, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1216193 · Cited by 12

Polarization and asymmetry in T cell metabolism

Kamiński, M. M., Liedmann, S., Milasta, S., & Green, D. R. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.10.002 · Cited by 11

Exploiting immunometabolism and T cell function for solid organ transplantation

Allocco, J., & Alegre, M. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104068 · Cited by 11

To Remember or to Forget: The Role of Good and Bad Memories in Adoptive T Cell Therapy for Tumors

Mondino, A., & Manzo, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01915 · Cited by 11

Immunometabolism Modulation in Therapy

Monferrer, E., Sanegre, S., Vieco-Martí, I., López-Carrasco, A., Fariñas, F., Villatoro, A. J., Abanades, S., Mañes, S., de la Cruz‐Merino, L., Noguera, R., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9070798 · Cited by 12

The Crucial Roles of Intermediate Metabolites in Cancer

Huang, S., Wang, Z., & Zhao, L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s321433 · Cited by 11

Metabolic cross-talk between ovarian cancer and the tumor microenvironment—providing potential targets for cancer therapy

Lin, Y., Liang, X., Zhang, X., Ni, Y., Zhou, X., & Zhao, X. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2704139 · Cited by 11

Phospho-enol pyruvate carboxykinase inhibition limits effector function in inflammatory T cells

Brownlie, R. J., Hope, H. C., Wright, D., Cook, G. P., Perales, J. C., & Salmond, R. J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1706167 · Cited by 1

Targeting PKM2 Enhances the Anti-Tumor Function of CD8+ T Cells Through Metabolic Reprogramming

Zhang, J., Wu, S., Yin, Q., Liu, Y., Zheng, S., & Yang, P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177664

Phospho-enol pyruvate carboxykinase inhibition limits inflammatory T cell activationPreprint

Brownlie, R. J., Hope, H. C., Wright, D., Cook, G. P., Perales, J. C., & Salmond, R. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.09.675120

Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy

Markowitz, G. J., Ban, Y., Tavarez, D. A., Yoffe, L., Podaza, E., He, Y., Martin, M. T., Crowley, M. J. P., Sandoval, T. A., Gao, D., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01963-1 · Cited by 60

Metabolic regulation of CD8 T cell functions in the tumor microenvironment

Qiu, J. (2017) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7w957m8